Advertisement

Topics

Celsion Company Profile

14:28 EDT 23rd March 2019 | BioPortfolio

Founded in 1982, with a vision of using heat to kill cancer and treat other diseases, Celsion began trading publicly in 1985 under the name Cheung Laboratories, Inc. The early research focus of the Company was device oriented heat-based treatment systems. The Company was renamed Celsion Corporation and listed on the American Stock Exchange under the symbol CLN, in the mid 1990's. At that time, Celsion focused its efforts on expanding the Company's research portfolio and licensed technologies for the treatment of Benign Prostatic Hyperplasia (BPH), breast cancer and heat activated drug and gene delivery systems. In 2001, Celsion determined that the greatest potential for long term shareholder value was in the Company's heat activated liposomal drug delivery system and focused its resources on obtaining approval for, commercializing and monetizing its BPH technology. The BPH product has been approved by the FDA and is being marketed as the Prolieve Thermodilatation® system by Celsion's exclusive distributor Boston Scientific Corporation. Under the distribution agreement Boston Scientific has a five year (expiring in February 2009) option to purchase the Prolieve® assets for $60 million. The funds generated to date through the commercialization of Prolieve have been used to develop the company's first drug ThermoDox™ (doxorubicin encapsulated in the company's heat activated liposome) to treat cancer. Celsion is currently engaged in two Phase I dose escalation studies for the treatment of liver cancer and breast cancer patients with loco-regional recurring chest wall cancer.

Location

10220-L Old Columbia Rd
Columbia
MD
21046
United States of America

Contact

Phone: 410.290.5390
Fax: 410.290.5394
Email: celsion@celsion.com


News Articles [6 Associated News Articles listed on BioPortfolio]

Celsion Corporation (CLSN) CEO Michael Tardugno on Q3 2018 Results - Earnings Call Transcript

Celsion Corporation (CLSN) To Present At Oppenheimer 29th Annual Healthcare Conference - Slideshow

Celsion Corp CLSN Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryCelsion Corp Celsion is an oncology company that strives to develop a portfolio of new cancer treatments, including directed chemotherapies, RNA or DNA based therapies and immunotherapies. The ...

Celsion Corp CLSN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryCelsion Corp Celsion is an oncology company that strives to develop a portfolio of new cancer treatments, including directed chemotherapies, RNA or DNA based therapies and immunotherapies. The ...

Celsion Corp CLSN Medical Equipment Deals and Alliances Profile [Report Updated: 24042018] Prices from USD $250

SummaryCelsion Corp Celsion is an oncology company that focuses on developing a portfolio of new cancer treatments, including directed chemotherapies, RNA based therapies and DNAmediated immunotherapy...

Global Nano Pharmaceutical Market Status and Outlook 20182025 [Report Updated: 02082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Celsion Corporation

Celsion is dedicated to the development and commercialization of innovative oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat-...

Celsion

Founded in 1982, with a vision of using heat to kill cancer and treat other diseases, Celsion began trading publicly in 1985 under the name Cheung Laboratories, Inc. The early research focus of the Co...

More Information about "Celsion" on BioPortfolio

We have published hundreds of Celsion news stories on BioPortfolio along with dozens of Celsion Clinical Trials and PubMed Articles about Celsion for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celsion Companies in our database. You can also find out about relevant Celsion Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Benign Prostatic Hyperplasia (BPH)
An enlarged prostate (benign prostatic enlargement (BPE) or benign prostatic hyperplasia (BPH)) is common in men after the age of about 50. Having an enlarged prostate does not mean you have cancer. In some cases, an enlarged prostate can cause the ...


Corporate Database Quicklinks



Searches Linking to this Company Record